4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001193125-25-284935
Chief Operating Officer sold 131,411 shares at an average $16.04 ($2,108,067)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bensen Daniel · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-13 | Sale : show line 1 in the form 10b5-1 | −1,111 | $16.00 | $17,780 | 426,870 | D |
| 2025-11-14 | Sale : show line 2 in the form 10b5-1 | −110,228 | $16.02 | $1,765,489 | 316,642 | D |
| 2025-11-17 | Sale : show line 3 in the form 10b5-1 | −18,572 | $16.11 | $299,191 | 298,070 | D |
| 2025-11-17 | Sale : show line 4 in the form 10b5-1 | −1,500 | $17.07 | $25,607 | 296,570 | D |
| Open-market sales · 131,411 sh · avg $16.04 · $2,108,067 | ||||||
Loading xslF345X05/ownership.xml…